Functional Involvement of TANK‐Binding Kinase 1 in the MyD88‐Dependent NF‐κB Pathway Through Syk

Abstract

Inflammation is a vital immune defense mechanism regulated by Toll‐like receptors (TLRs) and the nuclear factor‐kappa B (NF‐κB) pathway. TANK‐binding kinase 1 (TBK1) is central to immunity and inflammation and influences antiviral responses and cellular processes. However, the precise role of TBK1 in modulating the NF‐κB pathway through interactions with other proteins, such as spleen tyrosine kinase (Syk), remains poorly understood. As dysregulation of TBK1 and NF‐κB can lead to a variety of diseases, they are important therapeutic targets. In this work, inflammatory processes involving the TBK1‐Syk‐NF‐κB pathway were elucidated using lipopolysaccharide (LPS)‐induced macrophages; human embryonic kidney 293 (HEK293) cells overexpressing MyD88, TBK1, and Syk proteins and their mutants; and real‐time polymerase chain reaction (PCR), immunoblotting analyses, and kinase assays. TBK1 was activated in LPS‐, poly I:C‐, and Pam3CSK‐stimulated macrophages. Transcript levels of TNF, NOS2, and IL1B were increased in cells overexpressing TBK1 but not in cells overexpressing TBK1 K38A. The transcription of TNF, NOS2, and IL1B and NF‐κB luciferase activity were inhibited by silencing TBK1 in LPS‐stimulated RAW264.7 cells and MyD88‐transfected HEK293 cells. Syk was the key mediator of the TBK1‐dependent NF‐κB pathway and bound directly to the coiled coil domain of TBK1, which was necessary to activate Syk and the Syk‐p85 pathway. This research advances the understanding of the role of TBK1 in NF‐κB signaling, emphasizing Syk as a key mediator. The interaction between TBK1 and Syk has potential for precise immune modulation that can be applied to treat immune‐related disorders.